Indications for proton therapy: who is eligible for treatment
Proton therapy is particularly suitable for solid tumours located near vital organs
Proton therapy is indicated for patients with solid tumours located near critical organs, in paediatric oncology, and in cases requiring re-irradiation. It is the treatment of choice when precise dose delivery is crucial for preserving adjacent healthy tissue. The indication is determined by the medical team at the Cancer Centre of the Clinica Universidad de Navarra following an individual assessment of each case.
Do you need us to help you?
Complete this form and our specialists will contact you to discuss the case.
Treatment of choice for different types of cancer
Recommended Indications for Proton Therapy
1. Pediatric patients
- Indicated for most pediatric tumors where cure or long-term survival is anticipated.
2. Adults
- Intraocular and orbital tumors.
- Primary tumors located at the skull base, including chordoma and chondrosarcoma.
- Primary paraspinal and retroperitoneal sarcomas.
- Hepatocellular carcinoma, especially in patients with impaired liver function.
- Cases requiring craniospinal irradiation.
- Low-grade gliomas of the CNS.
- Benign CNS tumors located near radiosensitive structures where the full dose cannot be delivered using conventional techniques.
- Head and neck tumors, mainly advanced nasopharynx, oropharynx, paranasal sinuses, nasal cavity, and salivary glands.
- Mediastinal lymphomas.
- Re-irradiation.
- Tumors showing a dosimetric benefit and currently under clinical investigation: breast, lung, prostate, gynecologic, and bladder cancers.
Who is eligible for proton therapy?
The suitability of proton therapy is determined by the medical team at the Cancer Centre at the Clinica Universidad de Navarra following an individual assessment of each case. If you have been diagnosed with cancer and would like to know whether proton therapy is an option for your treatment, you can request an assessment through our Second Opinion service.